Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes

Takeshi Yagihashi, Takahide Hashimoto, Naoki Ohtake, Tokiko Okamoto, Bo-Shi Zhang, Yoichi Yoshida, Masaya Yamaga, Tomohiko Yoshida, Amika Kajiyama, Rikako Furukawa, Takaki Hiwasa, Minoru Takemoto

Open source

DOI: 10.1507/endocrj.ej26-0170
Published: 2026
Container: Endocrine Journal
Publisher: Japan Endocrine Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1507/endocrj.ej26-0170,
  title = {Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes},
  author = {Takeshi Yagihashi and Takahide Hashimoto and Naoki Ohtake and Tokiko Okamoto and Bo-Shi Zhang and Yoichi Yoshida and Masaya Yamaga and Tomohiko Yoshida and Amika Kajiyama and Rikako Furukawa and Takaki Hiwasa and Minoru Takemoto},
  year = {2026},
  journal = {Endocrine Journal},
  doi = {10.1507/endocrj.ej26-0170},
  url = {https://doi.org/10.1507/endocrj.ej26-0170}
}

RIS

TY  - JOUR
TI  - Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes
AU  - Takeshi Yagihashi
AU  - Takahide Hashimoto
AU  - Naoki Ohtake
AU  - Tokiko Okamoto
AU  - Bo-Shi Zhang
AU  - Yoichi Yoshida
AU  - Masaya Yamaga
AU  - Tomohiko Yoshida
AU  - Amika Kajiyama
AU  - Rikako Furukawa
AU  - Takaki Hiwasa
AU  - Minoru Takemoto
PY  - 2026
JO  - Endocrine Journal
DO  - 10.1507/endocrj.ej26-0170
UR  - https://doi.org/10.1507/endocrj.ej26-0170
ER  -

APA

Yagihashi, T., Hashimoto, T., Ohtake, N., Okamoto, T., Zhang, B., Yoshida, Y., Yamaga, M., Yoshida, T., Kajiyama, A., Furukawa, R., Hiwasa, T., & Takemoto, M. (2026). Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes. Endocrine Journal. https://doi.org/10.1507/endocrj.ej26-0170

Source records

crossref · retrieved 2026-09-26T22:53:25.549Z